Author
Listed:
- Can Küçük
(City of Hope Medical Center)
- Bei Jiang
(City of Hope Medical Center)
- Xiaozhou Hu
(City of Hope Medical Center)
- Wenyan Zhang
(West China Hospital of Sichuan University)
- John K. C. Chan
(Queen Elizabeth Hospital)
- Wenming Xiao
(National Center for Toxicological Research, Food and Drug Administration)
- Nathan Lack
(Koc University)
- Can Alkan
(Bilkent University)
- John C. Williams
(Beckman Research Institute of City of Hope)
- Kendra N. Avery
(Beckman Research Institute of City of Hope)
- Pınar Kavak
(Boğaziçi University)
- Anna Scuto
(City of Hope Medical Center)
- Emel Sen
(Koc University)
- Philippe Gaulard
(Groupe Henri-Mondor Albert-Chenevier, Inserm U955, Université Paris Est)
- Lou Staudt
(Molecular Biology of Lymphoid Malignancies Section, Center for Cancer Research, National Cancer Institute)
- Javeed Iqbal
(University of Nebraska Medical Center)
- Weiwei Zhang
(University of Nebraska Medical Center)
- Adam Cornish
(Cell Biology and Anatomy, University of Nebraska Medical Center)
- Qiang Gong
(Beijing Institute of Genomics, Chinese Academy of Sciences)
- Qunpei Yang
(West China Hospital of Sichuan University)
- Hong Sun
(West China Hospital of Sichuan University)
- Francesco d’Amore
(Aarhus University Hospital)
- Sirpa Leppä
(Helsinki University Central Hospital)
- Weiping Liu
(West China Hospital of Sichuan University)
- Kai Fu
(West China Hospital of Sichuan University)
- Laurence de Leval
(Pathologie Clinique Institut, Universitaire de Pathologie rue du Bugnon 25)
- Timothy McKeithan
(City of Hope Medical Center)
- Wing C. Chan
(City of Hope Medical Center)
Abstract
Lymphomas arising from NK or γδ-T cells are very aggressive diseases and little is known regarding their pathogenesis. Here we report frequent activating mutations of STAT3 and STAT5B in NK/T-cell lymphomas (n=51), γδ-T-cell lymphomas (n=43) and their cell lines (n=9) through next generation and/or Sanger sequencing. STAT5B N642H is particularly frequent in all forms of γδ-T-cell lymphomas. STAT3 and STAT5B mutations are associated with increased phosphorylated protein and a growth advantage to transduced cell lines or normal NK cells. Growth-promoting activity of the mutants can be partially inhibited by a JAK1/2 inhibitor. Molecular modelling and surface plasmon resonance measurements of the N642H mutant indicate a marked increase in binding affinity of the phosphotyrosine-Y699 with the mutant histidine. This is associated with the prolonged persistence of the mutant phosphoSTAT5B and marked increase of binding to target sites. Our findings suggest that JAK-STAT pathway inhibition may represent a therapeutic strategy.
Suggested Citation
Can Küçük & Bei Jiang & Xiaozhou Hu & Wenyan Zhang & John K. C. Chan & Wenming Xiao & Nathan Lack & Can Alkan & John C. Williams & Kendra N. Avery & Pınar Kavak & Anna Scuto & Emel Sen & Philippe Gaul, 2015.
"Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells,"
Nature Communications, Nature, vol. 6(1), pages 1-12, May.
Handle:
RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms7025
DOI: 10.1038/ncomms7025
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms7025. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.